Ratings by Cowen (Tyler Van Buren)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 2/6/2023 | BridgeBio Pharma | BBIO | New Coverage | Outperform (N/A) |
10.86 (11.42) |
5.16% | Details | |
| 1/30/2023 | Regeneron Pharma | REGN | Upgrade | Outperform (Market Perform) |
742.83 (794.81) |
7% | Details | |
| 1/25/2023 | Deciphera | DCPH | Maintain | Outperform (N/A) |
|
Details | ||
| 1/25/2023 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/6/2023 | Fate Therapeutics | FATE | Downgrade | Market Perform (Outperform) |
11.00 (6.78) |
-38.36% | Details | |
| 12/22/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Outperform (N/A) |
|
Details | ||
| 12/9/2022 | Deciphera | DCPH | Maintain | Outperform (N/A) |
|
Details | ||
| 11/9/2022 | Immunocore Holdings | IMCR | Maintain | Outperform (N/A) |
|
Details | ||
| 11/8/2022 | Gilead Sciences | GILD | Maintain | Outperform (N/A) |
|
Details | ||
| 11/3/2022 | Moderna | MRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 10/20/2022 | Regeneron Pharma | REGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 10/20/2022 | Moderna | MRNA | Maintain | Outperform (N/A) |
|
Details | ||
| 8/29/2022 | Deciphera | DCPH | New Coverage | Outperform (N/A) |
14.85 (16.90) |
13.8% | Details | |
| 8/8/2022 | Immunocore Holdings | IMCR | New Coverage | Outperform (N/A) |
54.40 (61.88) |
13.75% | Details | |
| 8/3/2022 | Regeneron Pharma | REGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/20/2022 | Regeneron Pharma | REGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 7/12/2022 | Zentalis Pharmaceuticals | ZNTL | New Coverage | Outperform (N/A) |
27.16 (22.59) |
-16.83% | Details | |
| 6/22/2022 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 6/8/2022 | Mirati Therapeutics | MRTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 6/6/2022 | Turning Point Therapeutics Inc. | TPTX | Downgrade | Market Perform (Outperform) |
74.59 (76.01) |
1.9% | Details | |
| 5/4/2022 | Regeneron Pharma | REGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/20/2022 | Regeneron Pharma | REGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 4/18/2022 | Gilead Sciences | GILD | Maintain | Outperform (Outperform) |
|
Details | ||
| 4/6/2022 | Iovanace Biotherapeutics | IOVA | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/23/2022 | Moderna | MRNA | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/7/2022 | Gilead Sciences | GILD | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/4/2022 | Tyra Biosciences | TYRA | Maintain | Outperform (Outperform) |
|
Details | ||
| 3/1/2022 | Turning Point Therapeutics Inc. | TPTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/28/2022 | Arvinas Inc. | ARVN | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/24/2022 | Allogene | ALLO | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/17/2022 | Arvinas Inc. | ARVN | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/16/2022 | Mirati Therapeutics | MRTX | Maintain | Outperform (Outperform) |
|
Details | ||
| 2/4/2022 | Regeneron Pharma | REGN | Maintain | Market Perform (N/A) |
|
Details | ||
| 1/31/2022 | Moderna | MRNA | Maintain | Market Perform (Market Perform) |
|
Details | ||
| 1/27/2022 | Moderna | MRNA | Maintain | Market Perform (N/A) |
|
Details | ||
| 12/13/2021 | Fate Therapeutics | FATE | Maintain | Outperform (N/A) |
|
Details | ||
| 12/13/2021 | Allogene | ALLO | Maintain | Outperform (N/A) |
|
Details | ||
| 12/7/2021 | Olema Pharmaceuticals | OLMA | New Coverage | Outperform (N/A) |
10.47 (4.71) |
-55.01% | Details | |
| 12/7/2021 | Iovanace Biotherapeutics | IOVA | New Coverage | Outperform (N/A) |
16.55 (8.39) |
-49.31% | Details | |
| 12/7/2021 | Regeneron Pharma | REGN | New Coverage | Market Perform (N/A) |
635.16 (794.81) |
25.14% | Details | |
| 12/7/2021 | CRISPR Therapeutics | CRSP | New Coverage | Market Perform (N/A) |
70.09 (55.62) |
-20.64% | Details | |
| 12/7/2021 | Fate Therapeutics | FATE | New Coverage | Outperform (N/A) |
48.00 (6.78) |
-85.88% | Details | |
| 12/7/2021 | Moderna | MRNA | New Coverage | Market Perform (N/A) |
306.72 (173.38) |
-43.47% | Details | |
| 12/7/2021 | Arvinas Inc. | ARVN | New Coverage | Outperform (N/A) |
74.44 (35.09) |
-52.86% | Details | |
| 10/20/2021 | Kronos Bio Inc. | KRON | New Coverage | Outperform (N/A) |
16.49 (2.34) |
-85.81% | Details | |
| 10/20/2021 | Rocket Pharmaceuticals | RCKT | New Coverage | Outperform (N/A) |
27.59 (20.44) |
-25.92% | Details | |
| 10/20/2021 | Gilead Sciences | GILD | New Coverage | Outperform (N/A) |
65.90 (86.40) |
31.11% | Details | |
| 10/20/2021 | Allogene | ALLO | New Coverage | Outperform (N/A) |
15.73 (7.75) |
-50.73% | Details | |
| 10/20/2021 | Allogene | ALLO | New Coverage | Outperform (N/A) |
15.73 (7.75) |
-50.73% | Details | |
| 10/11/2021 | Tyra Biosciences | TYRA | New Coverage | Outperform (N/A) |
16.26 (13.11) |
-19.37% | Details |
